Trial intelligence / Profile preview

Remimazolam vs propofol for colonoscopy sedation

CTR20180875Phase 3Completed

Sponsor
Hengrui Therapeutics
Start
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of remimazolam in None, sponsored by Hengrui Therapeutics. Started Jun 2018; status: completed.

02

Drugs

remimazolam

Beyond the preview

Go deeper on CTR20180875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20180875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call